Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.
4.

Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.

Smith U, Gogg S, Johansson A, Olausson T, Rotter V, Svalstedt B.

FASEB J. 2001 Jan;15(1):215-220.

PMID:
11149909
5.

Insulin-induced up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in fetal brown adipocytes.

Valverde AM, Arribas M, Mur C, Navarro P, Pons S, Cassard-Doulcier AM, Kahn CR, Benito M.

J Biol Chem. 2003 Mar 21;278(12):10221-31. Epub 2003 Jan 13.

6.
7.

Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.

Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR.

Mol Cell Biol. 2001 Jan;21(1):319-29.

9.

Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.

Mur C, Arribas M, Benito M, Valverde AM.

Endocrinology. 2003 Feb;144(2):581-93.

PMID:
12538620
10.

Mechanisms regulating adipocyte expression of resistin.

Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA.

J Biol Chem. 2002 May 31;277(22):19754-61. Epub 2002 Mar 18.

11.

Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.

Cabrero A, Alegret M, Sánchez RM, Adzet T, Laguna JC, Vázquez M.

FEBS Lett. 2000 Oct 27;484(1):37-42.

12.

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.

Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Moller DE.

Endocrinology. 1998 Dec;139(12):4920-7.

PMID:
9832429
13.

Synergistic activation of UCP-3 expression in cultured fetal rat brown adipocytes by PPARalpha and PPARgamma ligands.

Teruel T, Smith SA, Peterson J, Clapham JC.

Biochem Biophys Res Commun. 2000 Jul 5;273(2):560-4.

PMID:
10873645
14.
15.

Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.

Zierath JR, Ryder JW, Doebber T, Woods J, Wu M, Ventre J, Li Z, McCrary C, Berger J, Zhang B, Moller DE.

Endocrinology. 1998 Dec;139(12):5034-41.

PMID:
9832442
16.

Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart.

Young ME, Patil S, Ying J, Depre C, Ahuja HS, Shipley GL, Stepkowski SM, Davies PJ, Taegtmeyer H.

FASEB J. 2001 Mar;15(3):833-45.

PMID:
11259402
17.

Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.

Johnson TE, Vogel R, Rutledge SJ, Rodan G, Schmidt A.

Endocrinology. 1999 Jul;140(7):3245-54.

PMID:
10385421
18.

Skeletal muscle heterogeneity in fasting-induced upregulation of genes encoding UCP2, UCP3, PPARgamma and key enzymes of lipid oxidation.

Samec S, Seydoux J, Russell AP, Montani JP, Dulloo AG.

Pflugers Arch. 2002 Oct;445(1):80-6. Epub 2002 Jul 17.

PMID:
12397391
20.

Transcriptional regulation of uncoupling protein-2 gene expression in L6 myotubes.

Hatakeyama Y, Scarpace PJ.

Int J Obes Relat Metab Disord. 2001 Nov;25(11):1619-24.

PMID:
11753581

Supplemental Content

Support Center